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ABSTRACT 
Objective: Protective Effect of Acacia nilotica (Bark) against anti tubercular drugs induced hepatic damage an experimental study. 
Methods: Rats were divided into five different groups (n=6), the group I served as a control, Group II received Isoniazid-INH and rifampicin-
RIF(50mg/kg) in sterile water, group III and IV served as treatment and received 200,400 mg/kg of 50% ethonolic extract of A. nilotica, and group V 
served as standard group and received silymarin (100mg/kg). All the treatments were given for 10-28 days and after rats were euthenised, blood 
and liver was collected for biochemical and histopathological studies, respectively. 
Results: The 50% ethanolic bark extract of A. nilotica (200, 400 mg/kg p. o.) showed the remarkable hepatoprotective effect against Isoniazid-INH 
and rifampicin-RIF induced hepatic damage, and observed that it shows no any significant change in a normal posture, behavior and body weight in 
Wistar rats. The degree of protection was measured by biochemical and antioxidant parameters such as serum glutamate oxaloacetate 
transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT), alkaline phosphatase (ALP), total bilirubin, and the histopathological profile 
of liver also indicated the hepatoprotective nature of this drug.  
Conclusion: The bark extracts of A. nilotica has showed dose dependent activity, among which at the dose level of 200 & 400 mg/kg. The further 
investigations, the bark extract of Acacia nilotica identify the active constituents responsible for hepatoprotection.  
Keywords: A. nilotica, Antioxidant, Isoniazid-INH, Rifampicin-RIF, Silymarin. 
 
INTRODUCTION 
Liver is one of the largest organs in the human body and regulates 
homeostasis of the body [1] metabolic [2] 
A large number of plants and formulations have been claimed to 
have hepatoprotective activity Annona squamosa [6], Vitis vinifera 
[7], Momordica charantia [8], Zanthoxylum armatum [9], Tephrosia 
purpurea [10]. 
and excretory functions 
[3]. It involves almost all the biochemical pathways to growth, fight 
against disease, nutrient supply and reproduction [4]. 
Hepatotoxicity is a growing concern of today’s modern society and 
its rate has been reported to be much higher in developing countries 
like India (8-30%) compared to that in advanced countries (2-3%) 
with a similar dose schedule [5]. 
Acacia nilotica L. is a common, medium sized tree, locally known as 
‘Babul’ or ‘Kikar’ belonging to family Leguminosae [11]. It 
distributed throughout the greater part of India, Ceylon, Baluchistan, 
Egypt, Africa and its parts like bark, leave, pods and flower and 
widely used in various Ayurvedic formulations [12]. The various 
chemical constituents such as alkaloids, flavonoids, Glycoside, 
saponins, tannins, stearic acid, vitamin-C (ascorbic acid), carotene 
present in this plant [13-14]. A. nilotica has been reported as an 
effective medicine in the treatment of malaria, sore throat 
[15],asthma, cough, flu, rheumatism, hemorrhoid, and inflammation 
[16], liver infection (Hepatitis C Virus) 
Therefore, this study were aimed to evaluate the hepatoprotective 
activity of hydroethanolic extract of the A. nilotica (Bark) and also 
indicate possible mechanism for its hepatoprotection by 
investigation with biochemical and histopathological parameter 
against anti-tubercular drugs induced hepatotoxicity in rats. 
[17], cancers, tumors 
[18],congestion, diarrhoea, dysentery, hemorrhoids, ophthalmia, 
tuberculosis, leprosy and menstrual problems [19], plasmodial 
disease [20], bacterial disease [21], body vigour [22], wound healing 
[23], cytotoxicity [24], burning sensation [25], tonsillitis [26], 
platelets aggregation[27], helminthes infection [28], diabeties and 
hypolipidemia activity [29].  
MATERIALS AND METHODS 
Collection of plant material 
The fresh bark of the A. nilotica was collected in the month of May 
2013 from the National Botanical Research Institute Lucknow and 
plants were authenticated with excisted live specimen present in 
our Institutional Garden and herbarium prepared and deposited in 
the laboratory for future reference. 
Preparation of extract 
After collection and authentication, shade-dried bark (500g) of A. 
nilotica was powdered and extracted with of 50% ethanol at 500C on 
a water bath using Soxhlet extractor for 24 h. Then extract was 
filtered and concentrated under reduced pressure in a rotavapour 
(Buchi R-200 USA) at 450
Experimental animals 
C and then freeze-dried in lyophilizer 
(Labconco, USA) to obtain solid residue (ASE, yield 20.0% w/w).  
Albino wistar rats (150-200g) of either sex were taken from the 
animal house of the National Laboratory Animal Centre, Lucknow, 
India. They were kept under controlled conditions of temperature 
27±20C and relative humidity 44-56%, light/dark cycles of 12 hours 
respectively for one week before and during the experiments. 
Animals were provided with a standard rodent pellet diet (Amrut, 
India) and the food was withdrawn 18-24 h before the experiment 
though water was allowed ad libitum. All experiments were 
performed in the morning accordance with the current guidelines 
for the care of laboratory animals and the ethical guidelines for 
investigations of experimental pain in conscious animals [30] 
Preliminary phytochemical analysis 
approved by the Institutional Committee for Ethical use of Animals 
and Review Board (106/IAEC/RB/7-11). 
The 50% Ethanolic extract of A. nilotica (bark) was screened for the 
presence of various phytochemical constituents such as alkaloids 
(wager’s reagent), flavonoids (shinoda test), Glycoside 
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(Anthroquinone test), saponins (hemolysis test), tannins (ferric 
chloride test) and steroids (acetic anhydride test) as described by 
Trease and Evans [31] and Harborne [32] according to a previously 
described method for extraction. 
Induction of Hepatotoxicity and treatment  
Isoniazid-INH and rifampicin-RIF (50 mg/kg b. w.) [33] solution 
prepared in sterile distilled water and 50% ethanolic extact of A. 
nilotica bark in doses of 200, 400 mg/kg and Silymarin (100 mg/kg b. 
w.) administered orally twice daily at 10:00 and 16:00h respectively 
for 10-28 days. Rats were divided into six groups. Each group contains 
6 animals and followed as per the protocol given below:  
Group1 – Rats were treated with normal saline 
Group2 – Rats were treated with INH + RIF (50mg/kg) 
Group3 – Rats were treated with INH + RIF + A. nilotica (200 
mg/kg) 
Group4 – Rats were treated with INH + RIF + A. nilotica (400 
mg/kg) 
Group5 – Rats were treated with INH + RIF + Silymarin (100 
mg/kg) 
Animals were euthenised 48 after administration of the last dose. 
The blood samples were collected by cardiac puncture after an over-
night fast. The blood was allowed to coagulate at room temperature 
for 45 min and then centrifuged at 2500 rpm for 15 min for 
separation of serum. The serum was used for the biochemical 
analysis.  
Biochemical assessment 
The Biochemical parameters like serum enzymes: which includes 
aspartate aminotransaminase (AST), alanine aminotransaminase 
(ALT) [34], 
Histological investigation 
alkaline phosphatase (ALP) [35] and total billirubin [36] 
were assest. 
10% formalin solution was freshly prepared and the right liver lobe 
of the treated and control group was fixed in the solution for 48 
hours and subsequently dehydrated in alcohol, cleared with xylem 
and embedded in paraffin wax. Sections of lobe at about 5μm were 
mounted on glass slides and stained with haematoxylin and eosin 
[37]. 
Statistical analysis 
Data were analyzed by analysis of variance (ANOVA) followed by 
multiple Comparisons using Dunnett's procedure, to compare all 
groups against control and Student–Newman–Keul's procedure to 
compare all the groups pair wise. 
RESULTS 
Preliminary phytochemical analysis 
The 50% ethanolic bark extract of A. nilotica were screened for the 
presence of various phytochemical constituents such as alkaloids, 
flavonoids, glycoside, saponins, tannins and steroids. 
50% ethonolic bark extract of A. nilotica at a dose of 200 and 400 
mg/kg and standard drug Silymarin at a dose of 100mg/kg once 
daily for 28 days was subjected to observing body and liver weight 
in hepatotoxic rats. The study showed that the body weights were 
significantly decreased from (195.00 to 185.5 p<0.05) in RIF+INH 
groups. However, 50% ethonolic plant extracts showed normalize 
the body weight in a dose dependent manner. On comparing plant 
extract with Silymarin (100mg/kg) it shows that A. nilotica at 
200mg /kg is less effective than 400mg/kg plant extract. 
The study showed that the liver weight was increased from 6.30 ± 
0.07 to 7.53 ± 0.16 in RIF+INH groups. However, 50% ethonolic bark 
extracts of A. nilotica normalize liver weight in a dose dependent 
manner. Silymarin (100mg/kg) showed significant reduction in liver 
weight compared to RIF+INH groups (Table 1). 
 
Table 1: Effect of 50% ethonolic bark extract of A. nilotica on body and liver weight of RIF+ INH induced hepatotoxicity in Rats. 
Treatment/dose Body weight Liver weight 
Control 195.00±4.84 6.30±0.07 
RIF+ INH (50mg/kg) 185.5±3.51 7.53±0.16 
A. nilotica (200 mg/kg) 187.5 ±4.97* 6.60± 0.23** 
A. nilotica (400mg/kg) 188.5± 3.36** 6.46±0.10** 
Silymarin (100 mg/kg) 188.33± 3.34** 6.31±0.03** 
 Values are expressed as Mean ± SEM of 6 rats in each group. p<0.001 when compared to respective control and **
 
p<0.001 when compared to the 
respective RIF+INH control group. 
Table 2: Effect of A. nilotica on serum SGPT (U/L), SGOT (U/L), ALP (U/L) and Total Bilirubin level (mg/dL) against RIF+INH induced liver 
toxicity in rats. 
Treatment/Dose SGPT (IU/L) SGOT (IU/L) ALP (IU/L) Total Bilirubin(mg/dl) 
Control 58.74 ±7.740 106.28 ± 9.23 83.55 ± 6.52 0.54 ± 0.03 
RIF+INH(50mg/kg) 170.81 ± 7.55 223.72 ±15.87 138.27±7.97 1.76 ± 0.09 
A. nilotica 
(200mg/kg) 
92.46 ±4.73** 158.54± 8.00** 109.07 ± 8.33* 1.09 ± 0.14** 
A. nilotica 
(400mg/kg) 
64.09 ±3.76** 126.76±11.70** 89.64 ± 5.82** 0.61 ± 0.11** 
Silymarin (100mg/kg) 68.87 ± 4.23** 135.68± 3.77** 89.36 ± 5.74** 1.03 ± 0.10** 
Values are expressed in Mean ± SEM of 6 rats in each group. *p<0.01, **p<0.001 when compared with respective RIF+INH treated group. 
 
Effect of Test drug on SGPT, SGOT, ALP and Total Bilirubin 
It is clearly evident (Table 2) that RIF+INH caused a significant 
elevation of liver serum markers. In the RIF+INH treated group, the 
level of SGPT (58.74±7.74 to 170.81±7.55, p<0.001), SGOT 
(106.28±9.23 to 223.72±15.87, p<0.001), SALP (83.55 ±6.52 to 
138.27±7.97, p<0.001), Total Bilirubin (0.54±0.03 to 1.76±0.09, 
p<0.001). In contrast, the groups treated with 50% ethonolic bark 
extracts of A. nilotica at a dose of (200 and 400 mg/kg) once daily for 
28 days prevented the hepatotoxicity in a dose related manner. The 
ranges of protection in the serum marker were found to be SGPT 
(170.81±7.55 to 64.09±3.76, p<0.001), SGOT (223.72±15.87 to 
126.76±11.70, p<0.001), ALP (138.27±7.97 to 89.64 ± 8.33, p<0.01 
to p<0.001), Total Bilirubin (1.76±0.09 to 0.61±0.11, p<0.001). The 
protection of Silymarin ranged for SGPT (170.81±7.55 to 
68.87±4.23, p<0.001), SGOT (223.72±15.87 to 135.68±3.77, 
p<0.001), ALP (138.27 ± 7.97 to 89.36±5.74, p<0.001), Total 
bilirubin (1.76±0.09 to1.03±0.10, p<0.001) respectively. 
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The lipid peroxidation and the enzymatic and non-enzymatic 
antioxidant level in liver of experimental animals. Administration of 
RIF+INH led to increase in the levels of LPO (0.426±0.04 to 
4.43±0.39, p<0.001) and decrease in enzymatic scavenger viz. CAT 
(23.14±2.14 to 7.05±0.40, p<0.001), SOD (113.47±2.41 to 
54.36±3.52, p<0.001) levels in the liver homogenate. Treatment of 
rats with 50% ethonolic bark extracts of A. nilotica at dose of (200 - 
400 mg/kg) markedly prevented the RIF+INH 
  
induced alterations of 
various parameters like LPO (4.43±0.39 to 0.94±0.06, p<0.01 to 
p<0.001), CAT (7.05±0.40 to 20.37±0.76, p<0.001), SOD (54.36±3.52 
to 90.05±2.62, p>0.05 to p<0.001). The protection of Silymarin for 
LPO (4.43±0.39 to 0.79±0.06, p<0.001), CAT (7.05±0.40 to 
21.37±0.76, p<0.001), SOD (54.36±3.52 to 101.80±2.88, p<0.001), 
respectively (Table 3). 
Table 3: Effect of A. nilotica (bark) on liver LPO (MDA nmole/min/mg of protein), SOD (unit/mg of protein) and CAT (units/mg of protein). 
Treatment/Dose CAT (U/mg) SOD (U/mg) LPO (U/mg) 
Control 23.14 ± 2.14 113.47 ± 2.41 0.42 ± 0.04 
RIF+INH (50mg/kg) 7.05 ± 0.40 54.36 ± 3.52 4.43 ± 0.39 
A. nilotica (200mg/Kg) 15.16 ± 1.02* 79.20 ± 4.19* 3.27 ± 0.37* 
A. nilotica (400mg/Kg) 20.37 ± 0.76** 90.05 ± 2.62** 0.94 ± 0.06** 
Silymarin (100mg/Kg) 21.37 ± 0.76** 101.80 ± 2.88** 0.79± 0.06** 
Values are expressed as Mean ± SEM of 6 rats in each group.*p<0.01, **p<0.001, when compared with respective RIF+INH treated group. 
 
   
 
  
Fig. 1: A) Liver section of normal control rats showing normal hepatic cells. B) Liver sections of RIF+ INH (50 mg/kg)treated rats showing, 
massive fatty changes, necrosis, balloon formation, central vein congestion, loss of cellular boundaries
 
 and mononuclear inflammation. C) 
Liver sections of rats treated with RIF+ INH (50 mg/ kg) + A. nilotica extracts (200mg/kg) x 28 days, showing hepatic cells with well 
preserved cytoplasm, prominent nucleus, some of central veins and sinusoids exhibited congestion. D) Liver sections of rats treated with 
RIF+ INH (50 mg/ kg) + A. nilotica ethonolic bark extracts (400mg/kg) x 28 days showing well brought out central vein, hepatic cells with 
well preserved cytoplasms & prominent nucleus. E) Liver section of rats treated with RIF+INH (50mg/kg each) + Silymarin (100 
mg/kg)×28 days, showing, well brought out central vein, hepatic cell with well preserved cytoplasm, prominent nucleus & nearby normal 
liver architecture. 
Effect of A. nilotica bark Extract on Histopathology 
After assessing the liver histology, control group showed normal 
hepatic cells with the well preserved cytoplasm; well brought out 
Central veins; prominent nucleus in all animals. In RIF+ INH treated 
group, of animals showed RIF+ INH (50 mg/kg) treated rats 
showing, massive fatty changes, necrosis, balloon formation. 
Animals treated with RIF+ INH (50 mg/ kg) + A. nilotica extracts 
(200mg/kg & 400mg/kg) x 28 days, showing hepatic cells with well 
preserved cytoplasm, prominent nucleus, some of central veins and 
sinusoids exhibited congestion, hepatic cells with well preserved 
cytoplasms & prominent nucleus. Treatment with Silymarin showed 
recovery from toxicity (Fig. 1). 
DISCUSSION  
Tuberculosis (TB) is one of the most common infectious diseases in 
India; pulmonary tuberculosis is one of the major causes of adult 
deaths [38]. INH & RIF drug are considered to be first choice to treat 
a specific condition used for tuberculosis chemotherapy are 
associated with hepatotoxicity [39]. The administration of INH and 
RIF, the most common medication prescribed against tuberculosis, 
produces many metabolic and morphological aberrations in liver 
due to the fact that the liver is the main detoxifying site for these 
anti-tubercular drugs. These antitubercular drugs induce 
hepatotoxicity by a multiple step mechanism. Isoniazid is acetylated 
and then hydrolyzed, resulting in isonicotinic acid and monodactyl 
hydrazine; the later compound can be activated to a toxic species by 
cytochrome P-450 [40]. Rifampicin, a powerful inducer of drug 
metabolizing enzymes in man and rats contributes to the 
hepatotoxicity of ionized by enhancing the rate of production of 
toxic metabolites [41]. Hepatotoxicity is characterized by cirrhotic 
liver condition which in turn increased the bilirubin release [42].  
Tuberculosis is one of the fatal communicative diseases and is 
spread easily amongst people. Over one-third of the world's 
population is estimated to be infected with Mycobacterium 
tuberculosis and over 2 million people a year will die of the disease 
[43]. Multi-drug resistant (MDR) strains of M. tuberculosis have 
emerged and a co-infection with AIDS were reported.  
This turned out that the WHO declared tuberculosis as ‘Global health 
emergency [44].  
Evaluation of liver function can be made by estimating serum 
enzymes like SGOT, SGPT, ALP and Total Bilirubin, which present in 
higher concentration in cytoplasm. When there is hepatopathy, these 
enzymes leak into the blood stream in conformity with the extent of 
liver damage [45]. Normally SGOT and ALP are present in high 
concentration in liver, due to hepatocyte necrosis or abnormal 
membrane permeability; these enzymes are released from the cells 
and their levels in the blood increases [46]. 
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In the present study, the hepatotoxicity model in Wistar rats was 
successfully produced by administering INH and RIF (50 mg/kg per 
day each). All serum markers were markedly increases from above 
the normal limits of 28 days of the experiment that indicate liver 
injury.  
On primilary screening of Photochemical quantitative analysis of 
50% ethonolic bark extract of A. nilotica revealed the presence of 
alkaloids, flavonoids, Glycoside, saponins, tannins and steroids are 
the major chemical constituents. The Phytochemical screening of the 
bark extract of A. nilotica shows the presence of anti oxidative 
components. These are helpful in the hepatoprotection against 
RIF+INH induced liver injury in rats.  
CONCLUSION  
The present study showed that the 50% ethonolic bark extract of A. 
nilotica has Hepatoprotective effects that were proven by the 
biochemical and Histopathological analysis. The bark extract of A. 
nilotica has showed does dependent activity (200 & 400 mg/kg). 
However, further investigation, suggest that an extract of A. nilotica 
constituents responsible for hepatoprotection. 
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